Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy

Neuromuscul Disord. 2017 Aug;27(8):705-714. doi: 10.1016/j.nmd.2017.04.008. Epub 2017 Apr 28.

Abstract

The purpose of this study was to examine exercise effects on muscle water T2 in patients with Duchenne muscular dystrophy (DMD). In 12 DMD subjects and 19 controls, lower leg muscle fat (%) was measured by Dixon and muscle water T2 and R2 (1/T2) by the tri-exponential model. Muscle water R2 was measured again at 3 hours after an ankle dorsiflexion exercise. The muscle fat fraction was higher in DMD participants than in controls (p < .001) except in the tibialis posterior muscle. Muscle water T2 was measured independent of the degree of fatty degeneration in DMD muscle. At baseline, muscle water T2 was higher in all but the extensor digitorum longus muscles of DMD participants than controls (p < .001). DMD participants had a lower muscle torque (p < .001) and exerted less power (p < .01) during exercise than controls. Nevertheless, muscle water R2 decreased (T2 increased) after exercise from baseline in DMD subjects and controls with greater changes in the target muscles of the exercise than in ankle plantarflexor muscles. Skeletal muscle water T2 is a sensitive biomarker of the disease status in DMD and of the exercise response in DMD patients and controls.

Keywords: Duchenne muscular dystrophy; Exercise; Fat fraction; Magnetic resonance imaging; Skeletal muscle; Water T(2).

MeSH terms

  • Adipose Tissue / diagnostic imaging
  • Adipose Tissue / physiology
  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Body Water / diagnostic imaging*
  • Body Water / physiology
  • Child
  • Cross-Sectional Studies
  • Exercise / physiology*
  • Humans
  • Linear Models
  • Lower Extremity / diagnostic imaging
  • Lower Extremity / physiopathology
  • Magnetic Resonance Imaging*
  • Male
  • Muscle, Skeletal / diagnostic imaging*
  • Muscle, Skeletal / physiopathology
  • Muscular Dystrophy, Duchenne / diagnostic imaging*
  • Muscular Dystrophy, Duchenne / drug therapy
  • Muscular Dystrophy, Duchenne / physiopathology

Substances

  • Adrenal Cortex Hormones